Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1478-6362

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis ; volume:19 ; number:1 ; day:11 ; month:3 ; year:2017 ; pages:1-8 ; date:12.2017
Arthritis Research & Therapy ; 19, Heft 1 (11.3.2017), 1-8, 12.2017

Keyword: Arzneimittelentwicklung
Arzneimitteldesign

Creator: Toro-Domínguez, Daniel

Contributor: Carmona-Saez, Pedro
Alarcón-Riquelme, Marta E.
SpringerLink (Online service)

DOI: 10.1186/s13075-017-1263-7

URN: urn:nbn:de:1111-201704027581

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:04 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Toro-Domínguez, Daniel
Carmona-Saez, Pedro
Alarcón-Riquelme, Marta E.
SpringerLink (Online service)

Other Objects (12)

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

Hochschulschrift

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

Hochschulschrift

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

Hochschulschrift

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico off-target activity models for early hazard identification

Tracembler – software for in-silico chromosome walking in unassembled genomes

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

In-vitro and in-silico evidence for oxidative stress as drivers for RDW

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

In silico repurposing of antipsychotic drugs for Alzheimer’s disease

In silico approaches supporting drug repurposing for Leishmaniasis : a scoping review

In-silico and in-situ optimization for enhanced synthesis of functional microgels

Related objects

Reset password